Our agenda and speakers

Welcome

Elizabeth Jaffee, Johns Hopkins University School of Medicine

09:55 – 10:40

Keynote address
Chair: Elizabeth Jaffee, Johns Hopkins University School of Medicine
Speaker: Allan Balmain, University of California San Francisco

Pre-cancer biology & interception opportunities
Co-chairs: Irene Ghobrial, Harvard Medical School
Simon Leedham, University of Oxford 

Speakers: Jen Morton, Cancer Research UK Scotland Institute

Emerging researchers’ flash talks
Talks will be selected from abstracts

Panel session: Immune System Insights: The Role of Immune Dysfunction in Cancer Development and Prevention 

Chair: Tim Elliott, Cancer Research UK Oxford Center  

Integrated view of inequalities in cancer risk and incidence; how to achieve equitable cancer prevention?
Co-chairs: Melissa Davis, Morehouse School of Medicine
Neerja Bhatla, AIIMS (All India Institute of Medical Sciences, New Delhi)

08:15 – 08:50

Light breakfast

08:50 – 09:00

Opening remarks

Sarah Blagden, University of Oxford 

09:00 – 09:45

09:45 – 10:10

Emerging researchers’ flash talks
Talks will be selected from abstracts

10:10 – 10:40

Networking break and exhibition

10:40 – 12:40

The convergence of ageing, genetics and cancer risk/genesis; new opportunities for prevention
Co-chairs: Walid Khaled, Cambridge Stem Cell Institute
Ashani Weeraratna, John Hopkins

12:40 – 13:50

Lunch, exhibition and poster viewing

13:50  - 14:35

14:40 – 15:15

Debate: cancer prevention research should focus on understanding cancer risk, genesis and targets in
childhood and adolescence - waiting until late adulthood when risk is highest is too late to effectively prevent.

Chair: David Crosby, Cancer Research UK
For the motion: Yin Cao, Washington University School of Medicine
Against the motion: Annie Anderson, University of Dundee

15:15 – 15:45

Networking break and exhibition

15:45 – 16:45

Panel session: defining High-Risk in Cancer Prevention: A Patient and Public Perspective

Chair: William Dahut, Chief Scientific Officer, American Cancer Society (ACS)
Speakers: Carole Baas, Patient Advocate and University of Manchester
Emma Crosbie, Patient Advocate, 
Anna Fry, Patient Advocate
Steph Phillips, Patient Advocate

16:45 – 17:00

Closing remarks

17:00 – 18:00

Networking drinks and poster session

18:30 – late

Networking dinner

08:30 – 09:00

Light breakfast

09:00 – 09:05

Opening remarks
Marc Gunter, Imperial College London

09:05 – 09:20

American Cancer Society Atlas launch

09:20 – 11:20

Implementation of precision prevention interventions using repurposed drugs - can this realistically change practice  
Co-chairs: Pamela Goodwin, Sinai Health
Eva Szabo, National Cancer Institute

Speakers: Sir John Burn, Newcastle University

11:20 – 11:50

Networking break and exhibition

11:50 – 12:10

Emerging researchers’ flash talks
Talks will be selected from abstracts

12:15 – 13:00

Fireside chat

Sarah Blagden, University of Oxford 
Marc Gunter, Imperial College London
Elizabeth Jaffee, Johns Hopkins University School of Medicine

13:00 – 14:00

Lunch and exhibition

14:00 – 14:35

Debate session

Chair: David Crosby, Cancer Research UK
For the motion: Andrew Renehan, Manchester Cancer Research Centre   
Against the motion: Michael Pollak, McGill University

14:40 – 15:30

Panel session: can we ever really implement cancer prevention in the general population?

Chair: Linda Bauld, University of Edinburgh

15:30 – 15:45

Comfort break

15:45 – 16:30

Keynote address
Chair: Marc Gunter, Imperial College London
Speaker: Elisabete Weiderpass, International Agency for Research on Cancer

16:30 – 16:50

Closing remarks and conference close